Alexandre Lobo-da-Cunha

Prof. Dr. Alexandre Lobo-da-Cunha

1. Department of Microscopy, Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, Rua de Jorge Viterbo Ferreira, No. 228, 4050-313 Porto, Portugal
+1
orcid

Research Focus & Metrics

Academic Career Length

39Years (1988-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2005 in Journal of Experimental Marine Biology and Ecology
Verified
Journal Article
Closed access
EKEnikö Kádár
Enikö Kádár
Raul BettencourtRaul Bettencourt
Raul Bettencourt
VCValentina Costa
Valentina Costa
RSRicardo Santos
Ricardo Santos
Alexandre Lobo-da-CunhaAlexandre Lobo-da-Cunha
Alexandre Lobo-da-Cunha
PDPaul Dando
Paul Dando

15 April 2015 in The Journal of Pathology
Verified
Journal Article
Open access
PDF file
NPNelma Pertega‐Gomes
Nelma Pertega‐Gomes
SFSergio Felisbino
Sergio Felisbino
CMCharlie Massie
Charlie Massie
JVJose R Vizcaino
Jose R Vizcaino
RCRicardo Coelho
Ricardo Coelho
LFLee Gd Fryer
Lee Gd Fryer
Metabolic adaptation is considered an emerging hallmark of cancer, whereby cancer cells exhibit high rates of glucose consumption with consequent lactate production. To ensure rapid efflux of lactate, most cancer cells express high levels of monocarboxylate transporters (MCTs), which therefore may constitute suitable therapeutic targets. The impact of MCT inhibition, along with the clinical impact of altered cellular metabolism during prostate cancer (PCa) initiation and progression, has not been described. Using a large cohort of human prostate tissues of different grades, in silico data, in vitro and ex vivo studies, we demonstrate the metabolic heterogeneity of PCa and its clinical relevance. We show an increased glycolytic phenotype in advanced stages of PCa and its correlation with poor prognosis. Finally, we present evidence supporting MCTs as suitable targets in PCa, affecting not only cancer cell proliferation and survival but also the expression of a number of hypoxia‐inducible factor target genes associated with poor prognosis. Herein, we suggest that patients with highly glycolytic tumours have poorer outcome, supporting the notion of targeting glycolytic tumour cells in prostate cancer through the use of MCT inhibitors. © 2015 Authors. Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain and Ireland.

2 September 2019 in Cell and tissue research
Verified
Journal Article
Closed access
PDF file
Alexandre Lobo-da-CunhaAlexandre Lobo-da-Cunha
Alexandre Lobo-da-Cunha

1 December 2011 in International Journal of Systematic and Evolutionary Microbiology
Verified
Journal Article
Open access
JBJoana Bondoso
Joana Bondoso
LALuciana Albuquerque
Luciana Albuquerque
MNM. Fernanda Nobre
M. Fernanda Nobre
Alexandre Lobo-da-CunhaAlexandre Lobo-da-Cunha
Alexandre Lobo-da-Cunha
MCMilton Da Costa
Milton Da Costa
Olga LageOlga Lage
Olga Lage
As part of a study of the diversity of planctomycetes, two novel strains, designated OJF2T and OJF8, were isolated from the sediments of a freshwater aquarium. The organisms were chemoheterotrophic, spherical and pink-pigmented, had an optimum growth temperature of about 30–35 °C and an optimum pH for growth of around 7.5–8.5. The predominant fatty acids were C18 : 1ω9c and C16 : 0. The two strains were able to assimilate several sugars and organic acids. 16S rRNA gene sequence analysis confirmed the affiliation of these organisms to the phylum ‘Planctomycetes’; they showed highest similarity to the type strains of Singulisphaera acidiphila (92.4 %) and Isosphaera pallida (91.9 %). On the basis of physiological, biochemical and chemotaxonomic characteristics, strains OJF2T and OJF8 are considered to represent a novel species of a new genus of the order Planctomycetales, for which the name Aquisphaera giovannonii gen. nov., sp. nov. is proposed. The type strain of Aquisphaera giovannonii is OJF2T ( = CECT 7510T = DSM 22561T).

1 February 2015 in Systematic and Applied Microbiology
Verified
Journal Article
Closed access
JBJoana Bondoso
Joana Bondoso
LALuciana Albuquerque
Luciana Albuquerque
MNM. Fernanda Nobre
M. Fernanda Nobre
Alexandre Lobo-da-CunhaAlexandre Lobo-da-Cunha
Alexandre Lobo-da-Cunha
MCMilton Da Costa
Milton Da Costa
Olga LageOlga Lage
Olga Lage

11 April 2019 in Microbiologyopen
Verified
Journal Article
Open access
RSRita Severino
Rita Severino
HFHugo J. C. Froufe
Hugo J. C. Froufe
CBCristina Barroso
Cristina Barroso
LALuciana Albuquerque
Luciana Albuquerque
Alexandre Lobo-da-CunhaAlexandre Lobo-da-Cunha
Alexandre Lobo-da-Cunha
CEConceicao Egas
Conceicao Egas
Gaiella occulta strain F2‐233T (=CECT 7815 = LMG 26412), isolated from a 150 meter deep mineral water aquifer, was deemed a candidate for high‐quality draft genome sequencing because of the rare environment from which it was isolated. The draft genome sequence (QQZY00000000) of strain F2‐233T is composed of approximately 3 Mb, predicted 3,119 protein‐coding genes of which 2,545 were assigned putative functions. Genome analysis was done by comparison with the other deep‐branching Actinobacteria neighbors Rubrobacter radiotolerans, Solirubrobacter soli and Thermoleophilum album. The genes for the tricarboxylic acid cycle, gluconeogenesis and pentose phosphate pathway, were identified in G. occulta, R. radiotolerans, S. soli and T. album genomes. Genes of the Embden–Meyerhof–Parnas pathway and nitrate reduction were identified in G. occulta, R. radiotolerans and S. soli, but not in the T. album genome. Alkane degradation is precluded by genome analysis in G. occulta. Genes involved in myo‐inositol metabolism were found in both S. soli and G. occulta genomes. A Calvin–Benson–Bassham (CBB) cycle with a type I RuBisCO was identified in G. occulta genome, as well. However, experimental growth under several conditions was negative and CO2 fixation could not be proven in G. occulta.